These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

83 related articles for article (PubMed ID: 9716093)

  • 1. Funding for vaccination.
    Feris JM; Garib Z
    Lancet; 1998 Aug; 352(9127):579-80. PubMed ID: 9716093
    [No Abstract]   [Full Text] [Related]  

  • 2. Funding for vaccination.
    Milstien JB; Batson A
    Lancet; 1998 Aug; 352(9127):579. PubMed ID: 9716092
    [No Abstract]   [Full Text] [Related]  

  • 3. Hib vaccines for all the world's children?
    Clemens J; Jodar L
    Lancet; 2005 Jul 9-15; 366(9480):101-3. PubMed ID: 16005315
    [No Abstract]   [Full Text] [Related]  

  • 4. Development, evaluation and implementation of Haemophilus influenzae type b vaccines for young children in developing countries: current status and priority actions.
    Levine OS; Schwartz B; Pierce N; Kane M
    Pediatr Infect Dis J; 1998 Sep; 17(9 Suppl):S95-113. PubMed ID: 9781741
    [No Abstract]   [Full Text] [Related]  

  • 5. Economisation of vaccination against Haemophilus influenzae type b: a randomised trial of immunogenicity of fractional-dose and two-dose regimens.
    Lagos R; Valenzuela MT; Levine OS; Losonsky GA; Erazo A; Wasserman SS; Levine MM
    Lancet; 1998 May; 351(9114):1472-6. PubMed ID: 9605803
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Vaccine-preventable haemophilus influenza type B disease burden and cost-effectiveness of infant vaccination in Indonesia.
    Gessner BD; Sedyaningsih ER; Griffiths UK; Sutanto A; Linehan M; Mercer D; Mulholland EK; Walker DG; Steinhoff M; Nadjib M
    Pediatr Infect Dis J; 2008 May; 27(5):438-43. PubMed ID: 18398383
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Global use of Haemophilus influenzae type b conjugate vaccine.
    Ojo LR; O'Loughlin RE; Cohen AL; Loo JD; Edmond KM; Shetty SS; Bear AP; Privor-Dumm L; Griffiths UK; Hajjeh R
    Vaccine; 2010 Oct; 28(43):7117-22. PubMed ID: 20691265
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Positive effect of the introduction of Haemophilus influenzae type b vaccination in the expanded program on immunization in Cameroon.
    Massenet D; Tapindjin-Gake M
    Vaccine; 2010 Sep; 28(39):6404-5. PubMed ID: 20674879
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Foresight in medicine: current challenges with Haemophilus influenzae type b conjugate vaccines.
    Eskola J
    J Intern Med; 2010 Mar; 267(3):241-50. PubMed ID: 20201918
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Immunogenicity and safety of four different doses of Haemophilus influenzae type b-tetanus toxoid conjugated vaccine, combined with diphtheria-tetanus-pertussis vaccine (DTP-Hib), in Indonesian infants.
    Punjabi NH; Richie EL; Simanjuntak CH; Harjanto SJ; Wangsasaputra F; Arjoso S; Rofiq A; Prijanto M; Julitasari ; Yela U; Herzog C; Cryz SJ
    Vaccine; 2006 Mar; 24(11):1776-85. PubMed ID: 16303216
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Economic evaluation of Haemophilus influenzae type B vaccination in Indonesia: a cost-effectiveness analysis.
    Broughton EI
    J Public Health (Oxf); 2007 Dec; 29(4):441-8. PubMed ID: 17875589
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Getting Hib vaccine to those who need it.
    Booy R
    Lancet; 1998 May; 351(9114):1446-7. PubMed ID: 9605796
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Introduction of Haemophilus influenzae type B conjugate vaccine into routine immunization in Ghana and its impact on bacterial meningitis in children younger than five years.
    Renner LA; Newman MJ; Ahadzie L; Antwi-Agyei KO; Eshetu M
    Pediatr Infect Dis J; 2007 Apr; 26(4):356-8. PubMed ID: 17414404
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Perspective: a five-country analysis of the impact of four different Haemophilus influenzae type b conjugates and vaccination strategies in Scandinavia.
    Peltola H; Aavitsland P; Hansen KG; Jónsdóttir KE; Nøkleby H; Romanus V
    J Infect Dis; 1999 Jan; 179(1):223-9. PubMed ID: 9841843
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Haemophilus influenzae type b conjugate vaccine use and effectiveness.
    Morris SK; Moss WJ; Halsey N
    Lancet Infect Dis; 2008 Jul; 8(7):435-43. PubMed ID: 18582836
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Cost-effectiveness of Haemophilus influenzae type b conjugate vaccine program in Florida.
    Midani S; Ayoub EM; Rathore MH
    J Fla Med Assoc; 1995 Jun; 82(6):401-2. PubMed ID: 7643054
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Haemophilus influenzae type b diseases in Asia.
    Lau YL
    Bull World Health Organ; 1999; 77(11):867-8. PubMed ID: 10612880
    [No Abstract]   [Full Text] [Related]  

  • 18. Lessons learned during the development and transfer of technology related to a new Hib conjugate vaccine to emerging vaccine manufacturers.
    Hamidi A; Boog C; Jadhav S; Kreeftenberg H
    Vaccine; 2014 Jul; 32(33):4124-30. PubMed ID: 24923635
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Very good effect of Hib vaccination in Kenya].
    Gjersvik P
    Tidsskr Nor Laegeforen; 2006 Oct; 126(19):2554. PubMed ID: 17042086
    [No Abstract]   [Full Text] [Related]  

  • 20. Introducing new vaccines in the poorest countries: what did we learn from the GAVI experience with financial sustainability?
    Lydon P; Levine R; Makinen M; Brenzel L; Mitchell V; Milstien JB; Kamara L; Landry S
    Vaccine; 2008 Dec; 26(51):6706-16. PubMed ID: 18952134
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.